Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Maurer Barbara,

Beiträge für wissenschaftliche Veranstaltungen

Vortrag

Maurer, B; Kollmann, S; Pickem, J; Hoelbl-Kovacic, A; Sexl, V (2020): Stat5 - twins with different personalities JAK-STAT Pathways in Health & Disease; NOV 18-20, 2020; Cold Spring Harbor, New York, United States (USA). 2020.

Maurer, B; Uras, IZ, Jodl, P; Kollmann, K; Grausenburger, R; Zojer, M; Nivarthi, H; Kralovics, R; Sexl, V (2020): CDK6 is an essential signalling node in JAK2V617F-driven myeloproliferative diseases. 4th Symposium on Comparative Medicine; JAN 30-31, 2020; Vienna, Austria. 2020.

Maurer, B; Uras, IZ; Jodl, P; Kollmann, K; Prchal-Murphy, M; Kollmann, S; Nivarthi, H; Zojer, M; Grausenburger, R; Kralovics, R; Sexl, V (2020): CDK6 is an essential signaling node in JAK2V617F-mutant MPN. JAK-STAT Pathways in Health & Disease; Nov 18-20, 2020; Cold Spring Harbor, New York (virtual), United States (USA). 2020.

Maurer, B; Kollmann, S; Grundschober, E; Hoelbl-Kovacic, A; Sexl, V (2019): New insights in the roles of the fraternal twins STAT5A and STAT5B in hematopoiesis and leukemogenesis. 29. VetPharm-Symposium; OCT 10-11, 2019; Rauischholzhausen Castle, Gießen, Germany. 2019.

Neubauer, HA; Suske, T; Pham, HTT; Zahma, S; Tangermann, S; Prchal-Murphy, M; Maurer, B; Sexl, V; Valent, P; Boersma, A; Rülicke, T; Bekiaris, V; Kenner, L; Moriggl, R (2019): The gain of function STAT5B N642H mutation as a driver of mature T-Cell leukemia/lymphoma. Cytokines 2019: 7th Annual Meeting of the International Cytokine & Interferon Society; OCT 20-23, 2019; Vienna, Austria. 2019.

Neubauer, H; Pham, HTT; Suske, T; Spirk, K; Zahma, S; Tangermann, S; Prchal-Murphy, M; Maurer, B; Sexl, V; Valent, P; Boersma, A; Rülicke, T; Kenner, L; Moriggl, R (2018): The role of the gain-of-function STAT5BN642H mutation in the development of leukemia/lymphoma in different hematopoietic lineages. From Receptors and Kinases towards Transcriptional Regulators: Cancer Genome Landscapes and their Therapeutic Targets; MAY 6-9, 2018; Seggau, Stmk, Austria. 2018.

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Schlederer, M; Pham, HTT; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Muller, M; Rülicke, T; Moriggl, R (2016): Activated Stat5 Drives Peripheral T Cell Lymphomas. 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, Denmark, JUN 09-12, 2016. Haematologica (101), S1 567-567.

Poster

Maurer, B; Uras, IZ; Kollmann, S; Jodl, P; Kollmann, K; Prchal-Murphy, M; Nivarthi, H; Zojer, M; Grausenburger, R; Kralovics, R; Sexl, V (2019): CDK6 is an essential signaling node in JAK2V617F-mutant MPN. 44th FEBS Congress - from molecules to living systems; JUL 6-11, 2019; Krakow, Poland. 2019.

Maurer, B; Uras, IZ; Kollmann, S; Jodl, P; Kollmann, K; Prchal-Murphy, M; Nivarthi, H; Zojer, M; Grausenburger, R; Kralovics, R; Sexl, V (2019): CDK6 is an essential signaling node in JAK2V617F-mutant MPN. 44th FEBS Congress, From Molecules to Living Systems, Krakow, Poland, Jul 6‐11, 2019. FEBS Open Bio (9), S1 355-356.
Open Access Logo

Maurer, B; Bellutti, F; Kollmann, K; Sexl, V; Prchal-Murphy, M (2018): Uncoupling INK proteins from CDK4/CDK6 – how do hematopoietic stem cells react? Hematopoietic Stem Cells: From the Embryo to the Aging Organism, EMBL Conference; Jun 7-9, 2018; Heidelberg, Germany. 2018.

Maurer, B; Pham, HTT; Prchal-Murphy, M; Nivarthi, H; Wingelhofer, B; Schlederer, M; Grausenburger, R; Winkler, S; Halbritter, F; Farlik, M; Bock, C; Kenner, L; Kolbe, T; Rülicke, T; Müller, M [and 2 others] (2017): Graded STAT5A or STAT5B activity promote T-cell neoplasia. STATs: Importance In Basic & Clinical Cancer Research; Nov 15-18, 2017; Cold Spring Harbor, United States (USA). 2017.

Maurer, B; Nivarthi, H; Prchal-Murphy, M; Wingelhofer, B; Chen, D; Winkler, S; Prochazkova, J; Schlederer, M; Pham, H; Loizou, JI; Kenner, L; Sexl, V; Kolbe, T; Kralovics, R; Müller, M [and 2 others] (2015): An activating STAT5 mutation is sufficient for Peripheral T Cell Lymphoma formation. 3rd Annual Meeting of the International-Cytokine-and-Interferon-Society (ICIS), Bamberg, GERMANY, Germany, OCT 11-14, 2015. Cytokine (76), 1 77-77.

© Veterinärmedizinische Universität Wien Hilfe und DownloadsErklärung zur Barrierefreiheit